Indicators
Indicators
Value
Direction
MACD(12,26,9)
-1.304
Neutral
RSI(14)
42.916
Neutral
STOCH(KDJ)(9,3,3)
16.950
Neutral
ATR(14)
1.855
High Vlolatility
CCI(14)
-135.139
Sell
Williams %R
79.060
Sell
TRIX(12,20)
0.279
Sell
StochRSI(14)
25.279
Buy
Search
Omnicell Inc
OMCLAdd to Watchlist
40.840USD
-0.160-0.39%
Market hours （ET）Quotes delayed by 15 min
1.83BMarket Cap
91.58P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-0.49%
5 Days
-11.05%
1 Month
+1.67%
6 Months
-18.92%
Year to Date
-9.93%
1 Year
+44.32%
Key Figures
41.750Open
42.350High
120.87KVolume
91.58P/E TTM
17.71P/E Dynamic
--Dividend TTM
0.27%Turnover Ratio
41.000Prev. Close
40.880Low
4.00MTurnover
146.26P/E Static
1.50P/B
0.00%Div Yield TTM
0.98%ROA
55.00052wk High
0.63Volume Ratio
12.53MNet Profit
44.88MShares
0.4460EPS TTM
0.97Beta
1.63%ROE
26.84552wk Low
3.58%Amplitude
45.30%Gross Margin
1.83BMarket Cap
0.95Reward/Risk
2.29%Risk Rate
TradingKey Stock Score of Omnicell Inc
Currency: USD Updated: 2026-07-24Key Insights
Omnicell Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 26 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 61.29.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Omnicell Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Omnicell Inc Highlights
StrengthsRisks
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Overvalued
The company’s latest PE is 91.94, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 54.18M shares, decreasing 0.38% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 9.44K shares of this stock.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
61.286
Target Price
+53.75%
Upside Space
Omnicell Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
8
analysts
Buy
Current Rating
61.286
Target Price
+53.75%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Omnicell Inc
OMCL
8
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
41.754
Sell
MA10
44.108
Sell
MA20
43.692
Sell
MA50
42.470
Sell
MA100
40.097
Buy
MA200
40.122
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Omnicell Inc Info
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Ticker SymbolOMCL
CompanyOmnicell Inc
CEOLipps (Randall A)
Websitehttps://www.omnicell.com/
Shareholders
Related Instruments
-0.70%
-0.35%
+2.02%
+0.92%
-0.96%
+1.91%
+5.22%
+2.08%
+1.46%
-0.26%
+0.22%
+3.99%
+0.56%
-1.10%
-1.99%
+3.05%
+2.10%
+0.00%
-1.21%
-0.14%Popular Instruments
52210.400
+310.400 (+0.60%)
28014.200
-136.200 (-0.48%)
7420.800
+12.700 (+0.17%)
15103.000
+155.000 (+1.04%)
63951.000
-268.000 (-0.42%)
6313.700
+49.200 (+0.79%)
82.915
-7.128 (-7.92%)
336.700
+3.680 (+1.10%)
198.820
-8.020 (-3.88%)
4073.090
+20.740 (+0.51%)
FAQs
What is the current price of Omnicell Inc (OMCL)?
The current price of Omnicell Inc (OMCL) is 41.00.
What is the symbol of Omnicell Inc?
The ticker symbol of Omnicell Inc is OMCL.
What is the 52-week high of Omnicell Inc?
The 52-week high of Omnicell Inc is 55.00.
What is the 52-week low of Omnicell Inc?
The 52-week low of Omnicell Inc is 26.84.
What is the market capitalization of Omnicell Inc?
The market capitalization of Omnicell Inc is 1.86B.
Is Omnicell Inc (OMCL) currently rated as Buy, Hold, or Sell?
According to analysts, Omnicell Inc (OMCL) has an overall rating of Buy, with a price target of 61.29.
What is the Earnings Per Share (EPS TTM) of Omnicell Inc (OMCL)?
The Earnings Per Share (EPS TTM) of Omnicell Inc (OMCL) is 0.04.